• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Nasdaq Biotechnology Ishares ETF (NQ: IBB )

    145.73 +1.71 (+1.19%)
    Streaming Delayed Price Updated: 2:56 PM EDT, Jul 22, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 705,153
    Open 145.00
    Bid (Size) 145.74 (2)
    Ask (Size) 145.76 (4)
    Prev. Close 144.02
    Today's Range 144.12 - 146.02
    52wk Range 111.83 - 148.60
    Shares Outstanding N/A
    Dividend Yield 0.42%
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    The Market Requires 7 Pairs Of Eyes!
    A disjointed technical picture means that investors should respect the weaker seasonality. Investors should respect the strong sectors and not overthink. We have learned that regardless of political... 
    Via Talk Markets
    CPI Data Sparks Rally in Biotech Stocks
    Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market. 
    Via MarketBeat
    Topics ETFs Economy
    Exposures Interest Rates

    Performance

    YTD
    +5.55%
    +5.55%
    1 Month
    +6.11%
    +6.11%
    3 Month
    +15.56%
    +15.56%
    6 Month
    +7.45%
    +7.45%
    1 Year
    +12.60%
    +12.60%

    More News

    Read More
    Smalls And Mids Bios Try To Take The Lead While 2 Stocks Are On Watch For Pullback Entries
    Via Talk Markets
    Market Tries To Read Between The Lines
    Via Talk Markets
    Big Brother Biotechnology Sector Revives
    Via Talk Markets
    Weekly Visit With The Economy
    Via Talk Markets
    Topics Economy
    Exposures Economy
    TSLA Hit Our Target - Here’s What’s Next
    Via Talk Markets
    Topics Economy
    Exposures Interest Rates
    Can Momentum Build In Small Caps?
    Via Talk Markets
    Quarterly & Long-Term Portfolios For The Win
    Via Talk Markets
    3 Highly Rated Biotech Stocks for Your July Buy List
    Via InvestorPlace
    AbbVie Stock: A Perfect Dip for Investors to Buy
    Via MarketBeat
    Topics ETFs
    Tesla And Tech Are Still Taking The Bulls Higher
    Via Talk Markets
    Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
    Via MarketBeat
    Topics ETFs
    Exposures COVID-19
    Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows
    Via Benzinga
    Topics ETFs
    U.S. Centric Indicators
    Via Talk Markets
    Rags to Riches: 3 Biotech Stocks That Could Make Early Investors Rich
    Via InvestorPlace
    Wall Street Favorites: 3 Biotech Stocks With Strong Buy Ratings for June 2024
    Via InvestorPlace
    One Day Doth Not A Sector Rotation Make
    Via Talk Markets
    Tech Is Consolidating And The Market’s Seeking New Leadership
    Via Talk Markets
    Want to Earn More in the Stock Market With Less Effort? Try This Simple Strategy
    Via The Motley Fool
    Stocks Stall As Chip Sector Struggles To Rebound; Dollar Eyes 7-Week Peak, Gold, Bitcoin Retreat: What's Driving Markets Friday?
    Via Benzinga
    Gilead Sciences Stock Surges on HIV Treatment Trial Success
    Via MarketBeat
    Exposures Product Safety
    Weekly Update - Sunday, June 16
    Via Talk Markets
    Thoughts For Thursday: Tech Still Leading
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Large Cap BIopharmaceuticals Overview
    Via Talk Markets
    Topics Stocks
    Exposures US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.